Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1800794
PUBLISHER: IMARC | PRODUCT CODE: 1800794
Choroidal Neovascularization Market Report by Product Type, Diagnosis (Fluorescein Angiography, Indocyanine Green Angiography, Spectral Domain Optical Coherence Tomography, and Others), Treatment Type, Application, and Region 2025-2033
PUBLISHED:
PAGES: 124 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global choroidal neovascularization market size reached USD 6.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.13% during 2025-2033.
Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.
The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.
Key Market Segmentation:
Breakup by Product Type:
- Intravenous
- Intravitreal
Breakup by Type of Diagnosis:
- Fluorescein Angiography (FA)
- Indocyanine Green (ICG) Angiography
- Spectral Domain Optical Coherence Tomography (OCT)
- Others
Breakup by Treatment Type:
- Angiogenesis Inhibitors Injection
- Photodynamic Therapy
- Laser photocoagulation
- Low-dose Radiation Therapy
- Surgery
Breakup by Application:
- Extreme Myopia
- Malignant Myopic Degeneration
- Age-Related Developments
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).
Key Questions Answered in This Report:
- How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global choroidal neovascularization market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the type of diagnosis?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global choroidal neovascularization market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112025A2561
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Choroidal Neovascularization Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Intravenous
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Intravitreal
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Type of Diagnosis
- 7.1 Fluorescein Angiography (FA)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Indocyanine Green (ICG) Angiography
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Spectral Domain Optical Coherence Tomography (OCT)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Treatment Type
- 8.1 Angiogenesis Inhibitors Injection
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Photodynamic Therapy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Laser Photocoagulation
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Low-dose Radiation Therapy
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Surgery
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Application
- 9.1 Extreme Myopia
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Malignant Myopic Degeneration
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Age-Related Developments
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Bausch Health Companies Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Bayer AG
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Gilead Sciences, Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 F. Hoffmann-La Roche AG
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 SWOT Analysis
- 15.3.5 MaaT Pharma
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Novartis AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Pfizer Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Regeneron Pharmaceuticals Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.1 Bausch Health Companies Inc.
Product Code: SR112025A2561
List of Figures
- Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
- Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2024
- Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2024
- Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2024
- Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2024
- Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2024
- Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
- Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
- Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
- Figure 87: Global: Choroidal Neovascularization Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
- Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million USD), 2025-2033
- Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
- Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Choroidal Neovascularization Market Structure
- Table 8: Global: Choroidal Neovascularization Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.